Skip to contentSkip to Braille Studio

Library / Laws / 117th Congress / Senate Bills / S. 3449

S. 3449

To require foreign establishments engaged in the manufacture, preparation, propagation, compounding, or processing of a drug or device to register with the Food and Drug Administration regardless of whether the drug or device undergoes further manufacture, preparation, propagation, compounding, or processing at a separate establishment outside the United States prior to being imported into the United States.

Print stageDateSize⠃
Introduced in Senate2022-01-101.5K⠃⠗⠋